Last reviewed · How we verify

NCT05887622

The Potassium Supplementation Study

Recruiting now NA Last updated 11 June 2025
What this trial tests

NA trial testing Potassium chloride supplement in Cardiovascular Health in 30 participants. Currently enrolling.

Timeline
24 January 2022
Primary endpoint
31 December 2025
31 January 2026

Quick facts

Lead sponsorUniversity of Delaware
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment30
Start date24 January 2022
Primary completion31 December 2025
Estimated completion31 January 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Delaware

Who can join

Adults 18 to 45, any sex, with Cardiovascular Health or Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will test whether potassium supplementation can reduce the deleterious effect of a high sodium diet on blood vessel function, blood pressure reactivity and autonomic nervous system function in apparently healthy adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Health

Currently open trials in the same condition.

Other University of Delaware trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05887622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing